You would love this community. Looking forward to meeting you at the new members' meeting!
Original Message:
Sent: 3/27/2026 2:41:00 PM
From: Tabish Hussain
Subject: RE: New to ABRF
Hello everyone,
My name is Tabish Hussain, and I am a Research Investigator at the Advanced Technology Genomics Core at MD Anderson Cancer Center. My work focuses on next-generation sequencing technologies, including both Illumina and Oxford Nanopore platforms, where I support diverse projects ranging from bulk and single-cell transcriptomics to long-read sequencing applications.
With a background in oncology and molecular biology, I am particularly interested in translating genomic and epigenomic insights into meaningful biological and clinical outcomes. I also have experience in assay development, multi-omics integration, and collaborative research across interdisciplinary teams.
This is my first time attending ABRF, and I'm truly excited to be here and become part of this community. I look forward to learning from all of you, sharing experiences, and contributing to advancements in genomics technologies and core facility best practices.
See you all soon!
The information contained in this e-mail message may be privileged, confidential, and/or protected from disclosure. This e-mail message may contain protected health information (PHI); dissemination of PHI should comply with applicable federal and state laws. If you are not the intended recipient, or an authorized representative of the intended recipient, any further review, disclosure, use, dissemination, distribution, or copying of this message or any attachment (or the information contained therein) is strictly prohibited. If you think that you have received this e-mail message in error, please notify the sender by return e-mail and delete all references to it and its contents from your systems.
Original Message:
Sent: 3/26/2026 3:54:00 AM
From: Veronica De Sanctis
Subject: RE: New to ABRF
Hi Mrinmoyee and Barbara,
This will be my first ABRF Congress as well, and I'm really looking forward to it. I'll be traveling from Italy and am excited to finally meet you all in person.
Thanks, Barbara, for the information - I'm sure it'll be a great experience.
Best,
Veronica
------------------------------
Veronica De Sanctis
NGS facility Head
University of Trento and CTLS member
Trento
------------------------------
Original Message:
Sent: 03-25-2026 18:51
From: Barbara Fransway
Subject: New to ABRF
Mrinmoyee- I excited that you will join us at the ABRF annual meeting this year. You will be happy to know there are a large number of attendees that have overlapping expertise and professional interests (NGS, spatial, transnational genomics). We do have a genomics research group within the organization and they will have members in attendance. When you grab your ABRF badge at registration be sure to add the little flags that say "genomics", "first time attendee" and any others that seem relevant or fun. This will help people spot you for engagement as a new attendee and understand your field(s) of interest. Ill be in attendance the whole meeting and will look to introduce myself to you. Looking forward to a great meeting together!
Barbara
------------------------------
Barbara Fransway
Manager Genomic Research Services
University of Arizona
Tucson AZ
Original Message:
Sent: 03-25-2026 09:56
From: Mrinmoyee Majumder
Subject: New to ABRF
Morning everyone,
This will be my first ABRF attendance. I run a Translational Science/ Genomics core at MUSC, Charleston, SC (Cancer Center). We provide all types of NGS services as well as Spatial.
Please let me know if there are groups that I can meet at the meeting or discussion that I can join.
Looking forward to meeting you all.
Thank you,
Mrinmoyee Majumder, Ph.D.
Director of Operations
Medical University of South Carolina
68 President Street, BE411
Charleston, SC 29425
"If you publish a manuscript including research supported by the Translational Science Lab Shared Resource, the Hollings Cancer Center recommends the following text to be placed in the acknowledgement section: "Supported in part by the Translational Science Lab Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313)."